193 related articles for article (PubMed ID: 18626428)
1. Intestinal flora, probiotics, and cirrhosis.
Guerrero Hernández I; Torre Delgadillo A; Vargas Vorackova F; Uribe M
Ann Hepatol; 2008; 7(2):120-4. PubMed ID: 18626428
[TBL] [Abstract][Full Text] [Related]
2. Gut microbiota and host metabolism in liver cirrhosis.
Usami M; Miyoshi M; Yamashita H
World J Gastroenterol; 2015 Nov; 21(41):11597-608. PubMed ID: 26556989
[TBL] [Abstract][Full Text] [Related]
3. Intestinal flora imbalance results in altered bacterial translocation and liver function in rats with experimental cirrhosis.
Zhang W; Gu Y; Chen Y; Deng H; Chen L; Chen S; Zhang G; Gao Z
Eur J Gastroenterol Hepatol; 2010 Dec; 22(12):1481-6. PubMed ID: 20739895
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiota and probiotics in chronic liver diseases.
Cesaro C; Tiso A; Del Prete A; Cariello R; Tuccillo C; Cotticelli G; Del Vecchio Blanco C; Loguercio C
Dig Liver Dis; 2011 Jun; 43(6):431-8. PubMed ID: 21163715
[TBL] [Abstract][Full Text] [Related]
5. Intestinal microflora in patients with liver cirrhosis.
Zhao HY; Wang HJ; Lu Z; Xu SZ
Chin J Dig Dis; 2004; 5(2):64-7. PubMed ID: 15612659
[TBL] [Abstract][Full Text] [Related]
6. Gut microbiota-related complications in cirrhosis.
Gómez-Hurtado I; Such J; Sanz Y; Francés R
World J Gastroenterol; 2014 Nov; 20(42):15624-31. PubMed ID: 25400446
[TBL] [Abstract][Full Text] [Related]
7. Randomised clinical trial: the effects of a multispecies probiotic vs. placebo on innate immune function, bacterial translocation and gut permeability in patients with cirrhosis.
Horvath A; Leber B; Schmerboeck B; Tawdrous M; Zettel G; Hartl A; Madl T; Stryeck S; Fuchs D; Lemesch S; Douschan P; Krones E; Spindelboeck W; Durchschein F; Rainer F; Zollner G; Stauber RE; Fickert P; Stiegler P; Stadlbauer V
Aliment Pharmacol Ther; 2016 Nov; 44(9):926-935. PubMed ID: 27593544
[TBL] [Abstract][Full Text] [Related]
8. Potential benefits of pro- and prebiotics on intestinal mucosal immunity and intestinal barrier in short bowel syndrome.
Stoidis CN; Misiakos EP; Patapis P; Fotiadis CI; Spyropoulos BG
Nutr Res Rev; 2011 Jun; 24(1):21-30. PubMed ID: 20961485
[TBL] [Abstract][Full Text] [Related]
9. Probiotics in Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis, and Cirrhosis.
Qamar AA
J Clin Gastroenterol; 2015; 49 Suppl 1():S28-32. PubMed ID: 26447961
[TBL] [Abstract][Full Text] [Related]
10. Bacterial translocation (BT) in cirrhosis.
Wiest R; Garcia-Tsao G
Hepatology; 2005 Mar; 41(3):422-33. PubMed ID: 15723320
[TBL] [Abstract][Full Text] [Related]
11. Recurrent bacterial translocation from gut and sepsis in Head and neck cancer patients and its prevention by probiotics.
Gunduz M; Murakami D; Gunduz I; Tamagawa S; Hiraoka M; Sugita G; Hotomi M
Med Hypotheses; 2018 Nov; 120():124-127. PubMed ID: 30220331
[TBL] [Abstract][Full Text] [Related]
12. Role of intestinal bacterial overgrowth and intestinal motility in bacterial translocation in experimental cirrhosis.
Sánchez E; Casafont F; Guerra A; de Benito I; Pons-Romero F
Rev Esp Enferm Dig; 2005 Nov; 97(11):805-14. PubMed ID: 16438624
[TBL] [Abstract][Full Text] [Related]
13. Effect of Lactobacillus johnsonii La1 and antioxidants on intestinal flora and bacterial translocation in rats with experimental cirrhosis.
Chiva M; Soriano G; Rochat I; Peralta C; Rochat F; Llovet T; Mirelis B; Schiffrin EJ; Guarner C; Balanzó J
J Hepatol; 2002 Oct; 37(4):456-62. PubMed ID: 12217598
[TBL] [Abstract][Full Text] [Related]
14. Probiotics as modulators of the gut flora.
Fooks LJ; Gibson GR
Br J Nutr; 2002 Sep; 88 Suppl 1():S39-49. PubMed ID: 12215180
[TBL] [Abstract][Full Text] [Related]
15. Probiotics in non-alcoholic fatty liver disease: which and when.
Abenavoli L; Scarpellini E; Rouabhia S; Balsano C; Luzza F
Ann Hepatol; 2013; 12(3):357-63. PubMed ID: 23619251
[TBL] [Abstract][Full Text] [Related]
16. Bacterial translocation in patients with liver cirrhosis: physiology, clinical consequences, and practical implications.
Ponziani FR; Zocco MA; Cerrito L; Gasbarrini A; Pompili M
Expert Rev Gastroenterol Hepatol; 2018 Jul; 12(7):641-656. PubMed ID: 29806487
[TBL] [Abstract][Full Text] [Related]
17. Germ warfare: probiotics in defense of the premature gut.
Hammerman C; Bin-Nun A; Kaplan M
Clin Perinatol; 2004 Sep; 31(3):489-500. PubMed ID: 15325534
[TBL] [Abstract][Full Text] [Related]
18. Effects of the adjunctive probiotic VSL#3 on portal haemodynamics in patients with cirrhosis and large varices: a randomized trial.
Gupta N; Kumar A; Sharma P; Garg V; Sharma BC; Sarin SK
Liver Int; 2013 Sep; 33(8):1148-57. PubMed ID: 23601333
[TBL] [Abstract][Full Text] [Related]
19. Genomics can advance the potential for probiotic cultures to improve liver and overall health.
O'Sullivan DJ
Curr Pharm Des; 2008; 14(14):1376-81. PubMed ID: 18537660
[TBL] [Abstract][Full Text] [Related]
20. VSL#3 probiotic treatment decreases bacterial translocation in rats with carbon tetrachloride-induced cirrhosis.
Sánchez E; Nieto JC; Boullosa A; Vidal S; Sancho FJ; Rossi G; Sancho-Bru P; Oms R; Mirelis B; Juárez C; Guarner C; Soriano G
Liver Int; 2015 Mar; 35(3):735-45. PubMed ID: 24750552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
